Posts
RSSNotes and announcements from the Social Pain Institute — filings, research updates, and work in progress.
-
A third use for opioid medications
The Reagan-Udall Foundation for the FDA asked for comments on opioid medications for pain and addiction. We wrote about the use that was left out: low-dose buprenorphine for social pain, in conditions like BPD that have no approved medication.
Read more → -
Questions for the FDA nominee on 7-OH
The Senate HELP Committee questions Dr. Heidi Overton, nominee for FDA Commissioner, on September 24. We asked committee offices to raise the proposed scheduling of 7-OH, and the people it would leave without a care pathway.
Read more → -
Our comment on the proposed 7-OH threshold
Pain is the reason a person can state and be understood, and the most common one in this docket. 20.7% of comments also mention anxiety, depression, or trauma. We filed to put that group on the record.
Read more →